logo

SLRN(Delisted)

AcelyrinยทNASDAQ
--
--(--)

SLRN Profile

Acelyrin, Inc

A late-stage clinical biopharma company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines

--
07/27/2020
05/05/2023
NASDAQ Stock Exchange
83
12-31
Common stock
4149 Liberty Canyon Road, Agoura Hills, California 91301
--
Acelyrin, Inc was incorporated in Delaware on July 27, 2020. Acelyrin, Inc is a late-stage biopharmaceutical company focused on identifying, acquiring and accelerating the development and commercialization of transformative drugs. Since its inception, the Company has devoted almost all its resources to organizing the Company, recruiting personnel, business planning, acquiring and developing its product candidates, conducting research and development, manufacturing activities to support its product development efforts, building and protecting its intellectual property portfolio, raising funds and providing General And Administrative support for these activities.